Upgrade to SI Premium - Free Trial

Sage Therapeutics (SAGE) PT Lowered to $48 at RBC Capital

November 2, 2021 1:54 PM
RBC Capital analyst Brian Abrahams lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles